Cargando…
Folic Acid and Vitamin B12 Administration in CKD, Why Not?
Patients affected by chronic kidney disease (CKD) or end-stage renal disease (ESRD) experience a huge cardiovascular risk and cardiovascular events represent the leading causes of death. Since traditional risk factors cannot fully explain such increased cardiovascular risk, interest in non-tradition...
Autores principales: | Capelli, Irene, Cianciolo, Giuseppe, Gasperoni, Lorenzo, Zappulo, Fulvia, Tondolo, Francesco, Cappuccilli, Maria, La Manna, Gaetano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413093/ https://www.ncbi.nlm.nih.gov/pubmed/30781775 http://dx.doi.org/10.3390/nu11020383 |
Ejemplares similares
-
Vitamin D Effects on Bone Homeostasis and Cardiovascular System in Patients with Chronic Kidney Disease and Renal Transplant Recipients
por: Cianciolo, Giuseppe, et al.
Publicado: (2021) -
The Off-Target Effects, Electrolyte and Mineral Disorders of SGLT2i
por: Cianciolo, Giuseppe, et al.
Publicado: (2020) -
The Hydrogen Sulfide-Vitamin B12-Folic Acid Axis: An Intriguing Issue in Chronic Kidney Disease. A Comment on Toohey JI: “Possible Involvement of Hydrosulfide in B12-Dependent Methyl Group Transfer”. Molecules 2017, 22, 582, pii: E582
por: Cianciolo, Giuseppe, et al.
Publicado: (2017) -
Calcifying circulating cells: an uncharted area in the setting of vascular calcification in CKD patients
por: Cianciolo, Giuseppe, et al.
Publicado: (2016) -
Vitamin D and the Kidney: Two Players, One Console
por: Zappulo, Fulvia, et al.
Publicado: (2022)